Glenmark Pharmaceuticals standalone net profit declines 30.22% in the March 2017 quarter

Sales rise 12.74% to Rs 1938.56 crore

Net profit of Glenmark Pharmaceuticals declined 30.22% to Rs 357.06 crore in the quarter ended March 2017 as against Rs 511.72 crore during the previous quarter ended March 2016. Sales rose 12.74% to Rs 1938.56 crore in the quarter ended March 2017 as against Rs 1719.50 crore during the previous quarter ended March 2016.

For the full year,net profit rose 44.22% to Rs 2140.61 crore in the year ended March 2017 as against Rs 1484.27 crore during the previous year ended March 2016. Sales rose 30.27% to Rs 7694.83 crore in the year ended March 2017 as against Rs 5906.97 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales1938.561719.50 13 7694.835906.97 30 OPM %34.6729.97 -37.6729.88 - PBDT572.13571.94 0 2894.271846.35 57 PBT544.81545.88 0 2789.341746.54 60 NP357.06511.72 -30 2140.611484.27 44

Powered by Capital Market - Live News